Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126,273,814
-
Total 13F shares
-
58,271,447
-
Share change
-
+5,685,227
-
Total reported value
-
$238,328,151
-
Put/Call ratio
-
62%
-
Price per share
-
$4.09
-
Number of holders
-
107
-
Value change
-
+$24,483,565
-
Number of buys
-
50
-
Number of sells
-
54
Institutional Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) as of Q4 2023
As of 31 Dec 2023,
Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) was held by
107 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,271,447 shares.
The largest 10 holders included
MORGAN STANLEY, Soleus Capital Management, L.P., VANGUARD GROUP INC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, DEUTSCHE BANK AG\, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, and AQR CAPITAL MANAGEMENT LLC.
This page lists
107
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.